Phase1b recruited the first patient 18 months ago and they started with low dose. The first update was six months later.
Starting with the high dose they should know if it’s working in six months So stay tuned for reports or significant share price movement around August/September and be ready.
IMU Price at posting:
1.9¢ Sentiment: Buy Disclosure: Held